v3.26.3
General (Details Narrative) - Chemomab Therapeutics Ltd [Member] - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Losses from operations $ 116,000   $ 112,000    
Cash flows from operating activities 3,744 $ 6,144 11,130 $ 15,386 $ 23,611
Cash, cash equivalents, and short-term deposits $ 6,700   $ 10,400